Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD7789 for Relapsed or Refractory Classical Hodgkin's Lymphoma ...
Study on the Safety and Effectiveness of AZD7789 for Patients with ...
AZD7789 in NSCLC: safety, efficacy, and ongoing evaluation - VJOncology
阿斯利康:PD1/TIM3双抗报临床！国内仅1家布局 引言2022年5月24日，药审中心承办了 阿斯利康 的1类生物制品AZD7789的临床 ...
(PDF) 461 Generation of AZD7789, a novel PD-1 and TIM-3 targeting ...
阿斯利康AZD7789新适应症获批临床，能否带领PD-1/TIM-3双抗走向成功？|肿瘤_新浪财经_新浪网
阿斯利康：PD1/TIM3双抗报临床！国内仅1家布局 - 知乎
Phase II Evaluation of AZD7789, AZD0901, and Rilvegostomig in ...
免疫治療新進展！肺癌新藥AZD7789注射劑臨床！中外聯合開展! - 資訊咖
晚期肺癌有救了！肿瘤免疫疗法新药AZD7789成功在国内过审！_治疗_患者_临床
速递！阿斯利康抗PD-1/TIM-3双抗在中国获批临床|阿斯利康|临床|官网_新浪新闻
集中火力抗肿瘤！最新16款1类新药获批临床，阿斯利康、齐鲁在内 12月6日，据CDE官网，16款（治疗用生物制品10款，化药6款）1类新药获批 ...
PD1/TIM3双抗：阿斯利康报临床！国内仅1家布局_摩熵医药(原药融云)
Novel bispecific antibody-drug conjugate targeting PD-L1 and B7-H3 ...
速递！阿斯利康抗PD-1/TIM-3双抗在中国获批临床
Frontiers | PD-1/LAG-3 bispecific antibody potentiates T cell ...
Deciphering molecular and cellular ex vivo responses to bispecific ...
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is ...
阿斯利康 TIM-3/PD1 双抗国内又一项临床获批_Insight_数据库_全球
Blockade of PD1 and TIM3 Restores Innate and Adaptive Immunity in ...
Anti-PD-1 triggers TIM-3 expression on CD8+ TILs in a TNF-dependent ...
TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and ...
Immune checkpoint TIM-3 in tumor immunotherapy: Immune checkpoint TIM-3 ...
Full article: Adaptive resistance to anti-PD1 therapy by Tim-3 ...
Sequential administration of anti-PD-1 and anti-Tim-3 antibodies ...
抗体药物-PD-1&TIM-3-新闻资讯-德泰生物
Full article: A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 ...
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and ...
KK2845, a PBD dimer-containing antibody-drug conjugate targeting TIM-3 ...
(PDF) Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
| Characteristics of the anti-PD-1 monoclonal antibody used in this ...
Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab ...
AZD1775 and anti-PD-1 antibody synergistically sensitize hepatoma to ...
Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap ...
Frontiers | The bispecific antibody targeting VISTA and PD-L1 shows ...
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and ...
A Novel Recombinant Fusion Protein with Soluble PD-1 and TIM-3 Domains ...
Sequential administration of anti-PD-1 and anti-Tim-3 improved the ...
A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti ...
Expression of TIM3-related molecules in post-anti-PD-1 therapy samples ...
sonesitatug vedotin (AZD0901) / Keymed Biosciences, Lepu Med, AstraZeneca
Frontiers | Revealing the mechanisms and therapeutic potential of ...
Monoclonal Antibody Therapeutic Target Protein | Sino Biological
Targeting PI3Kβ alone and in combination with chemotherapy or ...
Bispecific Antibody Platform | Kyinno Bio
Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the ...
CD279 (PD-1) Monoclonal Antibody (eBioJ105 (J105)) (14-2799-80)
A bispecific antibody targeting HER2 and PD-L1 inhibits tumor growth ...
Full article: A strategy for the efficient construction of anti-PD1 ...
Anti-PD-1 antibody armored γδ T cells enhance anti-tumor efficacy in ...
Bispecific Antibodies for the Treatment of Cancer | Athena Publishing
Figure 1 from Bifunctional PD-1 x α CD 3 x α CD 33 fusion protein ...
724789-18-8_724789-18-8CAS号:724789-18-8/724789-18-8中英文名/分子式/结构式 – 960化工网
A Bifunctional Anti-PD-1/TGF-β Fusion Antibody Restores Antitumour ...
上海健信生物医药科技有限公司
Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade ...
(PDF) A BIVALENT TIM-3/PD-1 BISPECIFIC ANTIBODY FOR THE TREATMENT OF PD ...
Recombinant Human PD1 protein (ab280753) | Abcam
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co ...
Table 1 from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell ...
CD279 (PD-1) Monoclonal Antibody (J43), PE, eBioscience™ | Invitrogen ...
Antibody-drug Conjugate Information | ADCdb
Bispecific Antibodies in Cancer Immunotherapy - FineTest ELISA Kit ...
基于官方EVAL-AD7779FMCZ板的AD7779芯片开发教程_ad7770 程序-CSDN博客
Latest Advances and Applications of Bispecific Antibodies in Cancer ...
1397 ATG 027 a first in class B7 H3 PD L1 bispecific antibody shows ...
Full article: Combination of two novel blocking antibodies, anti-PD-1 ...
Frontiers | A Novel Bispecific Antibody Targeting PD-L1 and VEGF With ...
Molecular structures of (A) PD-1 antigen (PDB: 3RRQ) [44] and (B) TIM-3 ...
Bispecific Antibody Drug Conjugates (ADCs): Emerging Trends | Biopharma PEG
Bispecific antibody simultaneously targeting PD1 and HER2 inhibits ...
Synergistic efficacy of PI3Kδ inhibitor with anti-PD-1 mAbs in immune ...
CD279 (PD-1) Monoclonal Antibody (MIH4), eBioscience™ | Invitrogen (14 ...
最新16款1类新药获批临床！阿斯利康、齐鲁制药、荣昌生物在内 - 知乎
Discovery and characterization of two anti-PD-1 antibodies with a ...
CD279 (PD-1) Antibody, Super Bright™ 702 (67-2799-42)
Development of a bispecific antibody targeting PD-L1 and TIGIT with ...
